Kovitz Investment Group Partners LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Kovitz Investment Group Partners LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 0.8% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 17,028 shares of the healthcare conglomerate’s stock after buying an additional 141 shares during the period. Kovitz Investment Group Partners LLC’s holdings in UnitedHealth Group were worth $8,585,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Moneta Group Investment Advisors LLC lifted its holdings in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $5,210,004,000. Osaic Holdings Inc. lifted its holdings in shares of UnitedHealth Group by 776.9% during the second quarter. Osaic Holdings Inc. now owns 3,248,409 shares of the healthcare conglomerate’s stock valued at $177,941,000 after purchasing an additional 2,877,983 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after acquiring an additional 2,540,538 shares in the last quarter. Finally, Bank of Montreal Can purchased a new stake in UnitedHealth Group in the 2nd quarter worth about $1,087,367,000. Institutional investors own 85.69% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $2.80 during mid-day trading on Friday, reaching $517.29. The stock had a trading volume of 1,182,786 shares, compared to its average volume of 4,288,125. The firm’s 50 day simple moving average is $525.94 and its 200 day simple moving average is $517.66. The company has a quick ratio of 0.80, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The firm has a market cap of $478.45 billion, a PE ratio of 21.73, a P/E/G ratio of 1.41 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, topping analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter last year, the company earned $5.34 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.84 EPS for the current year.

Insider Buying and Selling

In related news, Director Stephen J. Hemsley sold 66,081 shares of the firm’s stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $550.39, for a total transaction of $36,370,321.59. Following the completion of the transaction, the director now owns 635,528 shares in the company, valued at approximately $349,788,255.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.35% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. HSBC reissued a “reduce” rating and issued a $480.00 price objective (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. StockNews.com lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, October 21st. Morgan Stanley dropped their target price on UnitedHealth Group from $587.00 to $579.00 and set an “overweight” rating on the stock in a research report on Monday, October 23rd. Piper Sandler dropped their target price on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 17th. Finally, Stephens reaffirmed an “overweight” rating and issued a $605.00 target price on shares of UnitedHealth Group in a research report on Thursday. One research analyst has rated the stock with a sell rating, one has issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $575.79.

Read Our Latest Stock Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.